The government's decisions to ease regulatory norms for clearing foreign-made vaccines for use in India and an in-principle consensus on an indemnity waiver are intended to facilitate supply of Pfizer's vaccine against Covid-19, which officials hope can be made by July.The government's decisions to ease regulatory norms for clearing foreign-made vaccines for use in India and an in-principle consensus on an indemnity waiver are intended to facilitate supply of Pfizer's vaccine against Covid-19, which officials hope can be made by July.